The regulation and rule effective entries on the firm's 2026 watchlist. Each event names what we are watching for and links to the most relevant insight on file.
Section 101 mandatory auto-enrollment for new 401(k)/403(b) plans starting after 12/29/2022 with full effect for 2025 plan year, first compliance window in 2026.
Watching for Whether participation moves from 62 percent to above 90 percent in newly mandated plans and how recordkeeper consolidation reacts.
EU Cyber Resilience Act enforcement window for products, plus DORA second-year operational resilience reporting and CISA CIRCIA proposed rule finalization.
Watching for Whether CIRCIA 72/24 hour windows go live and how cyber insurance pricing reacts to a year of NIS2 reporting data.
US GENIUS Act first compliance window for Tether and Circle plus EU MiCA second-year stablecoin issuer reporting under Title III.
Watching for Whether Tether brings reserve attestations into US GENIUS standard or accepts US offshoring, and how MiCA delisting flows reshape the European market share.
International Seabed Authority Council July session on the polymetallic nodule exploitation code. 2-year rule trigger from Nauru in 2021 active. 30+ states call for moratorium.
Watching for Whether Council reaches consensus on tax-and-royalty regime, environmental thresholds, and contractor liability framework.
Marine Environment Protection Committee adopts the legal text of the global fuel intensity standard and pricing mechanism approved at MEPC 83.
Watching for Whether the USD 100 per tonne base levy and USD 380 per tonne tier-2 surcharge survive intact, and the entry-into-force schedule.
ECB and European Commission Convergence Reports. Bulgaria's deferred euro adoption track from January 2025 to January 2026 to potentially January 2027.
Watching for Whether the inflation criterion finally clears and the lev redenomination calendar opens.
BIS first 12-month compliance review of the AI Diffusion Framework with Tier 2 country compute caps under National VEU and Universal VEU programs.
Watching for Whether Tier 2 caps adjust upward, how the Trump admin reframes the framework, and whether HBM controls survive the operational test.
Article 6 high-risk AI system obligations apply across all EU member states. CE marking, fundamental rights impact assessment, post-market monitoring obligations begin enforcement.
Watching for The first wave of AI Office investigations under high-risk classification, and member-state NCA capacity gaps.
High-risk AI compliance regime in Article 6, Annex III lands. Covers employment, education, critical infrastructure, law enforcement, migration, and credit scoring use cases.
Watching for First enforcement actions, AI Office testing protocols, and impact on US frontier model deployment in EU.
Western and Central Pacific Fisheries Commission northern committee review. WCPO 2.5 Mt baseline. Bell et al. 2021 Nature Sustainability projects 13 to 30 percent eastward redistribution by 2050.
Watching for Whether PNA Vessel Day Scheme floor price holds at USD 13,000+, and Kiribati fiscal exposure (64 percent dependence) mitigation.
ERCOT and the Texas PUC consider final rules on large flexible load registration, curtailment, and reliability obligations. The post-Senate-Bill-6 implementation cycle.
Watching for Whether the cost-allocation formula for hyperscaler load shifts from socialized to incremental.
IRA Section 30D Foreign Entity of Concern graphite material exclusion deadline. Atlas Public Policy clean-vehicle credit eligibility split into 268 / 87 / 38 billion clears, repriced, and stalls buckets.
Watching for Whether OEMs file lookback compliance and which battery cell capacity goes offline.
Carbon Border Adjustment Mechanism transitions from transitional to definitive period. UTPR (Pillar Two undertaxed payments rule) applies broadly.
Watching for First customs-revenue print under definitive CBAM and the UTPR application across the OECD inclusive framework.
CMS-negotiated maximum fair prices for the second cohort of 15 drugs (including Ozempic, Trulicity, Calquence) take effect.
Watching for The realized list-to-net price differential and Novo Nordisk and Eli Lilly margin response.